Vaccines broader value advisory board
On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.
During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making.
Also read
-
Is the risk of cancer the same for everyone?
Valery Lemmens (GROW) conducts research on cancer, prevention, and how society is designed for making unhealthy choices.
-
Most prestigious European grant to two UM scientists
Two Maastricht University professors are to receive the most prestigious European research grant for individual researchers: an ERC Advanced Grant, worth over €2.5 million. They are Lorenzo Moroni (MERLN) and Alexander Sack (FPN).
-
A new outlook on rehabilitation care
Ivan Huijnen (CAPHRI) aims to shift from the biomedical 'disorder-focused' thinking to an integral view on healthcare.
